Aspira Pathlab & Diagnostics Ltd

BSE: 540788

31

total announcements

540788.BO · 15 min delayed

BSECompany UpdateMgmt Change12 Aug 2026

Aspira Pathlab & Diagnostics Ltd

1. Board approved the appointment of Mr. Vaibhav Odhekar as Additional Executive Director with immediate Effect. 2. Board Approved the regularization of Mr. Vaibhav Odhekar as Executive ....

The Board of Directors of Aspira Pathlab & Diagnostics Ltd approved the appointment of Mr. Vaibhav Odhekar as Additional Executive Director with immediate effect, and also approved the regularization of Mr. Vaibhav Odhekar as Executive Director subject to approval of shareholders. The Board also approved the re-designation of Mr. Nikunj Velji Mange as Managing Director of the company, subject to approval of shareholders in the ensuing Annual General Meeting.

Read more →📎 1 attachment
BSEResultResults12 Aug 2026

Aspira Pathlab & Diagnostics Ltd

Unaudited Standalone Financial Results for quarter ended 30 June 2026

Aspira Pathlab & Diagnostics Ltd announced unaudited standalone financial results for the quarter ended June 30, 2026, along with the appointment of an internal auditor and additional executive director. The board also approved the re-designation of an executive director as managing director and regularized the appointment of another executive director. The company's financial results and other details are available on its website.

Read more →📎 1 attachment
BSEBoard MeetingMgmt Change12 Aug 2026

Aspira Pathlab & Diagnostics Ltd

Outcome of Board Meeting held on 12th August 2026

Aspira Pathlab & Diagnostics Ltd held a board meeting on August 12, 2026, where they approved the appointment of Harsh Kholiya & Co as internal auditors, Vaibhav Odhekar as additional executive director, and Nikunj Velji Mange as managing director. They also decided not to raise funds at this meeting.

Read more →📎 1 attachment
BSEBoard MeetingResults6 Aug 2026

Aspira Pathlab & Diagnostics Ltd

Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve 1.Unaudited Financial ....

Aspira Pathlab & Diagnostics Ltd has scheduled a board meeting on August 12, 2026, to consider and approve unaudited financial results for the first quarter ended June 30, 2026, and to consider a proposal for raising funds through a preferential issue of equity shares or warrants.

Read more →📎 1 attachment
← PreviousPage 2 of 2